Statement of solidarity and support to those affected by the Russian invasion of Ukraine
We, the EASL Governing Board, thus call on our fellow medical associations to join us in strongly condemning the invasion of Ukraine by the Russian Federation, carried out under the orders of…
Initiative to map the Cholangiocarcinoma landscape in Europe will help improve patient outcomes
Scientists advocate for education programmes to raise awareness and improve early diagnosis, survival, and quality of life of cholangiocarcinoma (CCA) patients in the largest and most complete multicentre study of CCA, published…
Honouring World Cancer Day 2022 to keep the liver top of the agenda
4 February 2022 On World Cancer Day, EASL focusses on the global threat of liver cancer and we draw attention to our goals and efforts so far, embedded in our policy and…
EASL journal JHEP Reports to receive its first impact factor in 2022
25 January 2022 It is with great pleasure that EASL announces that their first open-access journal JHEP Reports has been accepted into Clarivate’s Science Citation Index Expanded (SCIE) and Journal Citation Reports.…
International Liver Congress™ 2022 rescheduled to 22–26 June 2022
Savour science in the summer, together again, in London Message from EASL Secretary General, Prof. Thomas Berg. Dear friends, As governments across the world restrict travel and large-scale gatherings, the EASL Governing…
EASL events in February 2022 transition to being fully online
20 December 2021 This is an important announcement for our community engaged in fighting liver cancer and viral hepatitis. Given the current and evolving constraints and uncertainty triggered by COVID-19, the EASL…